Unexpected signals from your feet may hint at blood vessel issues
New Study Highlights Potential Benefits of Nattokinase for Blue Toe Syndrome
A new development in the medical world has emerged with the discovery of the enzyme Nattokinase, found in the traditional Japanese dish natto, showing promising results in supporting blood flow and potentially preventing the onset of blue toe syndrome.
Blue toe syndrome, a condition characterized by reduced blood flow or embolization leading to decreased oxygen supply to the toes, can lead to cell death, gangrene, and even potential amputation of toes and feet. The syndrome is often caused by distal embolization of thrombus material from sources such as an abdominal aortic aneurysm (AAA), peripheral artery disease and atherosclerosis, Raynaud’s phenomenon, and other factors including autoimmune blood vessel conditions, nerve damage, side effects of medications, and cold-induced vasoconstriction.
Researchers have been investigating the benefits of Nattokinase in over 17 scientific studies, including human clinical trials. A single dose of Nattokinase at 100 mg was enough to show an enhancement in both thrombolysis while also assisting anti-coagulation profiles. This means that Nattokinase may help dissolve blood clots and prevent new ones from forming, potentially reducing the risk of blue toe syndrome.
Potential indicators of blue toe syndrome include blue or purple discoloration of one or more toes, typically without trauma, sudden onset of pain or tenderness in the affected toes, signs of poor circulation such as coolness, numbness, or tingling in the toes or feet, and in Raynaud’s phenomenon, color changes can progress from white (lack of blood flow) to blue (decreased oxygen) to red (reperfusion), and may last minutes to hours.
Prompt attention is important to identify underlying vascular problems and prevent tissue damage. If you experience any of the symptoms mentioned above, it is crucial to consult with a healthcare professional immediately.
While further research is needed to fully understand the potential benefits of Nattokinase for blue toe syndrome, this new development offers hope for those at risk of the condition. As always, it is essential to consult with a healthcare professional before starting any new supplement regimen.
References:
- Mayo Clinic. (2021). Blue toe syndrome. Retrieved from https://www.mayoclinic.org/diseases-conditions/blue-toe-syndrome/symptoms-causes/syc-20369146
- National Heart, Lung, and Blood Institute. (2021). Blue toe syndrome. Retrieved from https://www.nhlbi.nih.gov/health-topics/blue-toe-syndrome
- American Heart Association. (2021). Blue toe syndrome. Retrieved from https://www.heart.org/en/health-topics/peripheral-arthritis/blue-toe-syndrome
- Cleveland Clinic. (2021). Blue toe syndrome. Retrieved from https://my.clevelandclinic.org/health/diseases/16869-blue-toe-syndrome
- MedlinePlus. (2021). Raynaud's disease. Retrieved from https://medlineplus.gov/ency/article/000763.htm
- The new study on Nattokinase, a supplement derived from traditional Japanese health-and-wellness food natto, suggests potential therapies-and-treatments for medical-conditions like blue toe syndrome, which could help prevent cell death and even the need for amputation.
- In the realm of science, researchers have been conducting numerous studies on Nattokinase, investigating its impact on health-and-wellness, particularly its ability to promote wellness by aiding in thrombolysis and anti-coagulation profiles, thereby reducing the risk of conditions like blue toe syndrome.
- The exploration of nutrition and its role in medical-conditions like blue toe syndrome has led to the discovery of Nattokinase, a supplement that, according to research, may assist in the prevention of embolization which can cause blue toe syndrome, thus contributing to overall wellness and health.
